Original Article

You have full text access to this OnlineOpen article

Effect of mammographic service screening on stage at presentation of breast cancers in Sweden

  1. Swedish Organised Service Screening Evaluation Group†,‡,*

Article first published online: 30 APR 2007

DOI: 10.1002/cncr.22671

Issue

Cancer

Cancer

Volume 109, Issue 11, pages 2205–2212, 1 June 2007

Additional Information

How to Cite

Swedish Organised Service Screening Evaluation Group (2007), Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer, 109: 2205–2212. doi: 10.1002/cncr.22671

Author Information

  1. †

    Authorship: Drafting CommitteeStephen W. Duffy, Cancer Research UK and Queen Mary University of London. László Tabár, Central Hospital, Falun and University of Uppsala, Sweden. Tony H.H. Chen, National Taiwan University. Robert A. Smith, American Cancer Society. Lars Holmberg (Chair of management committee), Regional Oncology Center, Uppsala, Sweden. Håkan Jonsson and Per Lenner, Department of Radiation Sciences, University of Umeå, Sweden. Lennarth Nyström, Department of Public Health and Clinical Medicine, University of Umeå, Sweden. Sven Törnberg, Oncologic Center, Karolinska University Hospital, Stockholm, Sweden. Jan Frisell, Karolinska University Hospital, Stockholm, Sweden.Statistical AnalysisAmy M.F. Yen, National Taiwan University. Li-Sheng Chen, National Taiwan University. Yueh-Hsiah Chiu, National Taiwan University. Chia-Yuan Wu, National Taiwan University. Hui-Min Wu, National Taiwan University. Chih-Chung Huang, National Taiwan University Jane Warwick, Queen Mary University of London. Levent Kemetli, Karolinska University Hospital, Stockholm. Patrick Chou, Queen Mary University of London.Project Leaders of the Screening ProgramsStockholm RegionGunilla Svane and Edward Azavedo, Karolinska University Hospital. Helen Grundström and Per Sundén, Danderyd Hospital. Karin Leifland, St. Göran Hospital. Kerstin Moberg, Södersjukhuset. Tor Sahlstedt, Skärholmen.Umeå RegionPal Bordás, Norrbotten. Leena Starck, Västernorrland. Stina Carlson, Västerbotten. Håkan Laaksonen, Jämtland.Uppsala RegionShahin Abdsaleh and Erik Thurfjell, Uppsala. Birgitta Epstein and Maria Tholin, Örebro. Ewa Frodis, Västmanland. Ann Sundbom, Värmland. László Tabár, Dalarna. Mika Wiege, Sörmland. Anders Åkerlund and Bengt Lundgren (deceased), Gävleborg.

  2. ‡

    Fax: (404) 325-2548.

*American Cancer Society, Cancer Control Department, 1599 Clifton Rd. NE, Atlanta, GA 30329

Publication History

  1. Issue published online: 18 MAY 2007
  2. Article first published online: 30 APR 2007
  3. Manuscript Accepted: 19 DEC 2006
  4. Manuscript Revised: 13 DEC 2006
  5. Manuscript Received: 11 OCT 2006

Funded by

  • The American Cancer Society

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (192K)

REFERENCES

  • 1
    SmithRA,DuffySW,GabeR,TabarL,YenAM,ChenTH. The randomized trials of breast cancer screening: what have we learned. Radiol Clin North Am. 2004; 42: 793–806.
  • 2
    NystromL,AnderssonI,BjurstamN,FrisellJ,NordenskjoldB,RutqvistLE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002; 359: 909–919.
  • 3
    Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organised service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev. 2006; 15: 45–51.
  • 4
    Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organised service screening with mammography: 2. Validation with alternative analytic methods. Cancer Epidemiol Biomarkers Prev. 2006; 15: 52–56.
  • 5
    JonssonH,NystromL,TornbergS,LennerP. Service screening with mammography of women aged 50–69 years in Sweden: effects on mortality from breast cancer. J Med Screen. 2001; 8: 152–160.
  • 6
    PaciE,DuffySW,GiorgiD, et al. Quantification of the effect of mammographic screening on fatal breast cancers: the Florence programme 1990–96. Br J Cancer. 2002; 87: 65–69.
  • 7
    FielderHM,WarwickJ,BrookD, et al. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen. 2004; 11: 194–198.
  • 8
    LennerP,JonssonH. Excess mortality from breast cancer in relation to mammography screening in northern Sweden. J Med Screen. 1997; 4: 6–9.
  • 9
    TabarL,DuffySW,VitakB,ChenHH,PrevostTC. The natural history of breast carcinoma: what have we learned from screening? Cancer. 1999; 86: 449–462.
  • 10
    EwertzM,DuffySW,AdamiHO, et al. Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer. 1990; 46: 597–603.
    Direct Link:
  • 11
    MorrisonAS. Intermediate determinants of mortality in the evaluation of screening. Int J Epidemiol. 1991; 20: 642–650.
  • 12
    TabarL,FagerbergG,DuffySW,DayNE,GadA,GrontoftO. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am. 1992; 30: 187–210.
  • 13
    TabarL,YenMF,VitakB,ChenHHT,SmithRA,DuffySW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003; 361: 1405–1410.
View Full Article (HTML) Get PDF (192K)